Better hypertension management: How to work with patients for improved BP resultsHow to work with patients for improved blood pressure results Blood pressure medication improves COVID-19 survival rates New Canadian statement on management of pulmonary hypertension Joint Canadian Cardiovascular Society–Canadian Thoracic Society statement outlines current approach to diagnosis and management of pulmonary hypertension First Canadian guidance document on management of syncope Canadian Cardiovascular Society issues first clinical practice guideline on assessment and management of syncope New evidence supports prescribing statins for primary prevention of CVD in the elderly New statin use lowers risk of all-cause and CV mortality in US veterans (75+ years) without atherosclerotic CVD at baseline Ertugliflozin provides benefits similar to other SGLT2 inhibitors VERTIS-CV trial results show no increased risk of cardiac events Use of antihypertensive drugs generates pressure-packed debate in COVID-19 era Researchers have been trying to understand a possible link between blood pressure medications and COVID-19 Antihypertensive deprescribing may be possible in some older patients with hypertension No substantial change in short-term blood pressure control, but long-term clinical outcomes uncertain 2020 Canadian hypertension guidelines now available, with separate guidelines for managing resistant cases Provide expert guidance on the prevention, diagnosis, risk assessment and treatment of hypertension in adults and children Hypertension professional certification program for pharmacists now available Hypertension Canada program provides pharmacists with knowledge and confidence to identify and manage patients with hypertension First Previous 21 22 23 24 25 Next Last
